Future studies should examine whether the effects we describe here for Cmpd 1 in the ZSF1 model setting translate to non-leptin models of obesity and whether they can be reasonably expected to extend to humans, in particular those afflicted by T2D. This evidence concerns the gene LEP and type 2 diabetes mellitus.